Varian Medical Systems has unveiled HyperArc high definition radiotherapy (HDRT) technology at the 2016 American Society for Radiation Oncology (ASTRO) annual meeting.
The technology has been developed for use in high definition radiotherapy and radiosurgery.
It enables clinicians to deliver more compact radiation doses that closely adjust tothe size, shape, and location of tumors while sparing more surrounding healthy tissue.
It will also allow clinicians to capitalize on the capabilities of Varian's TrueBeam and Edge treatment platforms, including the PerfectPitch couch.
The HyperArc treatment delivery technology is seeking FDA 510(k) clearance. Varian plans to make the new technology available for customers from early 2017.
Varian Oncology Systems president Kolleen Kennedy said: "This exciting new technology unlocks the potential of using highly non-coplanar treatment strategies to usher in a new era of precision in radiotherapy and radiosurgery for cancer patients.
"HyperArc is the first step into our OnComand ecosystem that Varian introduced to the community last year. It is designed to automate and simplify sophisticated treatments such as Stereotactic Radiosurgery (SRS), and make them available to more cancer patients around the world."
Varian produces medical devices and software for treating cancer and other medical conditions with radiation.
It also supplies X-ray imaging components, including tubes, digital detectors, cables and connectors as well as image processing software and workstations for use in medical and industrial settings.
Image: HyperArc technology allows clinicians to deliver more compact radiation doses. Photo: courtesy of Varian Medical Systems, Inc.